Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 13, 2025

Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M?

View original at finance.yahoo.com
Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M? Travis Wolfe / Shutterstock.com Quick Read Bitcoin trades around $90K after hitting $126K in October, marking a 26.3% correction from the peak…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Global ETF demand could exceed $500-$800 billion by 2030

    80% confidence

  • Bearish case projects Bitcoin at $120K-$220K if structural demand weakens and ETF inflows flatten

    80% confidence

  • Hundreds of publicly traded companies now hold Bitcoin following MicroStrategy's accumulation model

    80% confidence

  • Institutions now treat Bitcoin as a modern counterpart to gold for navigating unstable monetary conditions

    80% confidence

  • Bullish case projects Bitcoin at $750K-$1M by 2030 if ETF assets approach $2 trillion and sovereign reserves expand

    80% confidence

  • Bitcoin could reach $500K to $1M by 2030 depending on institutional demand, supply compression, and adoption patterns

    80% confidence

  • Price acceleration typically peaks 12-24 months after a halving event

    80% confidence

  • Banks now use Bitcoin as collateral in lending markets

    80% confidence

  • At $500K, Bitcoin's market cap would reach approximately $10 trillion, roughly 2% of global wealth and still below gold

    80% confidence

  • Base case projects Bitcoin at $350K-$500K with ETF assets moving toward $500-$800 billion range

    80% confidence

Data points we hold from this source

Bitcoin · daily issuance225 BTC
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M? — Source | Via News | Finance Via News